AzTrials
AzTrials

Feeding BehaviorNCT02998489

Effectiveness and Safety of Fast Enteral Feeding in Preterm Infants Between 1000 and 2000 Grams of Birth Weight

A study testing Fast milk advancement and Traditional milk advancement in people with Feeding Behavior, run by Hospital Universitario San Ignacio.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a randomized controlled trial with infants less than 34 weeks and between 1000 and 2000 grams at birth, that seeks to establish the safety and effectiveness of fast enteral advancement (milk 30-40 cc/kg/d) compared with traditional advancement (milk 20 cc/kg/d) Read more about this study

Who is it for?
Ages Up to 72 hours
Conditions the study is for
Feeding Behavior
What is being tested?
Fast milk advancement and Traditional milk advancement
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
No sites listed yet
Study dates
1 Apr 2014to 12 Sep 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 72 hours
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Infants less than 34 weeks of gestational age.
  • Weight at birth between 1000 and 2000 grams.
  • Infants hospitalized in the newborn unit at Hospital Universitario San Ignacio in Bogotá, Colombia.

Who cannot join

  • Perinatal Asphyxia
  • Intrauterine Growth Restriction
  • Diagnosis of Congenital Hearth Disease
  • Severe Hypoxemia
  • Major Congenital Malformations
  • Metabolic Disease
Show all 10Show fewer
  • Intolerance to initiate oral feeding at the eligibility
  • Patent Ductus with hemodynamic instability
  • Early Onset Sepsis with hemodynamic instability
  • Refusal of parents to participate in the study

About this study

Official title: Effectiveness and Safety of Rapid Enteral Feeding in Preterm Infants Between 1000 and 2000 Grams of Birth Weight

This is a randomized controlled trial with infants less than 34 weeks and between 1000 and 2000 grams at birth, that seeks to establish the safety and effectiveness of fast enteral advancement (milk 30-40 cc/kg/d) compared with traditional advancement (milk 20 cc/kg/d)

Read the detailed description

Progression of enteral feeding in preterm infants is still controversial. The neonatologist needs to provide adequate caloric intake avoiding the risk of food intolerance and necrotizing enterocolitis.

Objective: To establish the safety and effectiveness of fast enteral advancement compared with traditional advancement.

Design: A randomized controlled clinical trial with infants less than 34 weeks and between 1000 and 2000 grams at birth conducted at Hospital Universitario San Ignacio in Bogotá, Colombia.

Methods: 30 cc versus 20 cc / kg / day advancing in infants between 1000 and 1499g and 40cc versus 20 cc / kg / day advancing in infants between 1500 and 1999g.

Outcomes: days to reach full enteral nutrition, days of parenteral nutrition (PN) and/or intravenous fluids (IVF), days to regain birth weight, episodes of food intolerance, anthropometric measurements and weight gain at 40 weeks; rate of late onset sepsis, hypoglycemia, hyperbilirubinemia, necrotizing enterocolitis (NEC) and mortality. Data will be analyzed with Student t test or Mann-Whitney U-test and Pearson Chi-square or Fisher test. Multiple linear regression will be performed.

Ethics: This Protocol was approved by the Ethics and Research Committee of Pontificia Universidad Javeriana and San Ignacio Hospital. Informed consent will be requested to parents.

Being tested
Fast milk advancement, Traditional milk advancement
Keywords
enteral nutrition, infant,premature, feeding method
Medical subject headings
Feeding Behavior, Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fast milk advancementOther

    Also called Milk

    30-40 cc/kg/d of human milk or formula milk until total enteral feeding has been achieved

  • Traditional milk advancementOther

    Also called Milk

    20 cc/kg/d of human milk or formula milk until total enteral feeding has been achieved

Study groups in NCT02998489
Study groupRoleWhat they receive
Fast milk advancementExperimental30-40 cc/kg/d of human milk or formula milk administered by orogastric tube or by suction
Receives: Other: Fast milk advancement
Traditional milk advancementActive comparator20 cc/kg/d of human milk or formula milk administered by orogastric tube or by suction
Receives: Other: Traditional milk advancement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. days to reach full enteral nutrition

    number of days employed to reach full enteral nutrition with breast milk, formula milk or breast milk plus formula milk.

    Measured: number of days from date of randomization until the day that the baby reach full enteral nutrition or date of death from any cause assessed up to 12 weeks

  2. days of intravenous fluids

    number of days with intravenous fluids included parenteral nutrition and dextrose with electrolytes

    Measured: number of days of intravenous fluids from birth until suspension of them or date of death from any cause assessed up to 12 weeks

Secondary outcomes (11)
  1. days to regain birth weight

    number of days employed to regain birth weight

    Measured: number of days from birth, employed to regain birth weight or date of death from any cause assessed up to 12 weeks

  2. episodes of food intolerance

    number of episodes of food intolerance per day during hospitalization

    Measured: number of episodes of food intolerance per day from date of randomization until hospital discharge or date of death from any cause assessed up to 12 weeks

  3. weight at 40 weeks

    weight in grams at 40 weeks of post menstrual age

    Measured: weight at 40 weeks of post menstrual age

  4. length at 40 weeks

    length in centimeters at 40 weeks of post menstrual age

    Measured: length at 40 weeks of post menstrual age

  5. head circumference at 40 weeks

    head circumference in centimeters at 40 weeks of post menstrual age

    Measured: head circumference at 40 weeks of post menstrual age

  6. weight gain per day at 40 weeks of post menstrual age

    weight gain in gr./d from birth until 40 weeks of post menstrual age

    Measured: weight gain in grams per day from birth until 40 weeks of post menstrual age

  7. rate of necrotizing enterocolitis

    rate of necrotizing enterocolitis through study completion

    Measured: through study completion(from date of randomization until 40 weeks of post menstrual age)

  8. rate of mortality

    number of patients who died during the study's follow up

    Measured: through study completion(from date of randomization until 40 weeks of post menstrual age)

  9. rate of late onset sepsis

    number of patients who had late onset sepsis during hospitalization

    Measured: from date of randomization until hospital discharge or date of death from any cause assessed up to 12 weeks

  10. rate of hyperbilirubinemia

    number of patients who had hyperbilirubinemia and were treated with phototherapy during hospitalization

    Measured: from date of randomization until hospital discharge or date of death from any cause assessed up to 12 weeks

  11. rate of hypoglycemia

    number of patients who had hypoglycemia during hospitalization

    Measured: from date of randomization until hospital discharge or date of death from any cause assessed up to 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Dec 2016 (estimated)
  2. Study start1 Apr 2014
  3. Primary completion31 Dec 2015
  4. Study completion12 Sep 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02998489
Sponsor's protocol ID
2014/25
Status last verified
Mar 2018
First submitted
11 Dec 2016
Last updated
23 Mar 2018
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Publications

  • Morgan J, Young L, McGuire W. Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev. 2015 Oct 15;(10):CD001241. doi: 10.1002/14651858.CD001241.pub6.

    PubMed 26469124
  • Moore TA, Wilson ME. Feeding intolerance: a concept analysis. Adv Neonatal Care. 2011 Jun;11(3):149-54. doi: 10.1097/ANC.0b013e31821ba28e.

    PubMed 21730906

Questions about this trial

What is this clinical trial studying?

A study testing Fast milk advancement and Traditional milk advancement in people with Feeding Behavior, run by Hospital Universitario San Ignacio.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

days to reach full enteral nutrition (time frame: number of days from date of randomization until the day that the baby reach full enteral nutrition or date of death from any cause assessed up to 12 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02998489, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Mar 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in